Mead Johnson Nutrition Company (MJN) Shares are Down -3.09%

Mead Johnson Nutrition Company (MJN) : During the past 4 weeks, traders have been relatively bearish on Mead Johnson Nutrition Company (MJN), hence the stock is down -6.47% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -2.44% relative to the S&P 500. The 4-week change in the price of the stock is -6.67% and the stock has fallen -3.09% in the past 1 week.

For the current week, the company shares have a recommendation consensus of Buy. The stock has recorded a twenty day Moving Average of 4.47% and the fifty day Moving Average is 5.96%. Mead Johnson Nutrition Company is up 0.53% in the last three month period. Year-to-Date the stock performance stands at 6.55%.

Mead Johnson Nutrition Company (MJN) : The most positive equity analysts on Mead Johnson Nutrition Company (MJN) expects the shares to touch $96, whereas, the least positive believes that the stock will trade at $75 in the short term. The company is covered by 6 Wall Street Brokerage Firms. The average price target for shares are $87.67 with an expected fluctuation of $6.98 from the mean.


Mead Johnson Nutrition Company (NYSE:MJN): The stock was completely flat for the day, closing at $83.25 on Friday. The flat closing masks the intraday volatility in the stock. After opening at $83.48, the stock touched an intraday high of $84.22 and a low of $83.24. Neither the bulls nor the bears asserted their supremacy at close, due to which the stock closed completely flat. The stock previously closed at $83.25. The total trading volume on Friday was 923,462.

Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, childrens nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas, childrens milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company operates through three segments: Asia, Latin America and North America/Europe. The Companys Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.